Pulmonary Hypertension Flashcards
What is Pulmonary Hypertension?
When the normal blood pressure is higher in the LUNGS
What is the WHO classification of Pulmonary Hypertension?
Group 1[~3% of patients]
-With an unknown cause
-Treated with lung transplant or CCB
What is the epidemiology of PAH?
The epidemiology is unknown, but it could be caused by like certain medications
-2 to 8 cases per million each year [0.002%]
-Mainly causes problems on the right side of the heart
What are the signs and symptoms of PAH?
SOB [most common], Chest Pain, Fatigue, Edema, Light-Headedness
-Could also resemble COPD/Asthma
How do you determine the diagnosis of PAH?
-Echocardiogram
-Walking for 6 minutes
-Right Heart Catheterization [CONFIRMS IT]
-Other biomarkers
What are the effects on the body caused by PAH?
The pulmonary arterial wall becomes damaged, causing a decrease in blood flow to the lungs.
-Right side of the heart becomes larger
-Left side of the heart becomes smaller
What happens within the arteries when vascular injury occurs?
-Decrease in NO synthase
-Decrease Prostacyclin Production
-Increase Thromboxance Production
-Increase Endothelin 1 Production
*all will cause a start in vasoconstriction
What does Endothlin 1 do?
It is a potent vasoconstrictor
What are the WHO functional classes and difference between them?
-Class I: Symptom-free
-Class II: Slight Limitation; Comfortable at rest
-Class III: Marked Limitation; Comfortable at rest
-Class IV: Symptoms at rest
What is an Acute Vasoreactivity Test?
It is a test to see whether or not a patient is going to need to use a CCB or not.
-Recommended CCBs: Amlodipine, Nifedipine, Diltalizem
What is the treatment recommendations for a patient with WHO FC I?
Continue to monitor the disease progression and possibly determine a start of medication
What is the treatment recommendation for a patient with WHO FC II?
See if they can tolerate combo therapy;
-Yes: do Ambreisentan + Tadalafil
-No: Use a ERA, Riocigant, or PDE5 Inhibitor
What is the treatment recommendation for a patient with WHO FC III Low [without rapid progression]?
The same as WHO FC II
See if they can tolerate combo therapy;
-Yes: Ambrisentan + Tadalafil
-No: ERA, Riocigant, or PDE5 Inhibitor
What is the treatment recommendation for a patient with WHO FC III High [with rapid progression]?
See if they are a candidate for Parenteral prostanoids
-Yes: SC Treprostinil
-No: Inhaled or Oral Prostanoids
What is the treatment recommendation for a patient with WHO FC IV?
The same as WHO FC III High
*See if they are a candidate for Parenteral Prostanoids
-Yes: SC Treprostinil
-No: Oral Prostanoids